Antiparkinsonism drugs.
D000928:Antidepressive Agents / Q000627:therapeutic use*; D001285:Atropine / Q000627:therapeutic use*; D004155:Diphenhydramine / Q000627:therapeutic use*; D006801:Humans; D009966:Orphenadrine / Q000627:therapeutic use*; D010276:Parasympatholytics / Q000188:drug therapy* / Q000601:surgery*; D010300:Parkinson Disease / Q000627:therapeutic use*; D011398:Promethazine / Q000627:therapeutic use*; D012601:Scopolamine / Q000627:therapeutic use*; D014282:Trihexyphenidyl / Q000627:therapeutic use*
D000928:Antidepressive Agents; D010276:Parasympatholytics; D014282:Trihexyphenidyl; D001285:Atropine; D004155:Diphenhydramine; D009966:Orphenadrine; D012601:Scopolamine; D011398:Promethazine